Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Amgen
Hoffmann-La Roche
Lumos Pharma
Actuate Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Eisai Inc.
Vividion Therapeutics, Inc.
Centre Oscar Lambret
QuantumLeap Healthcare Collaborative
Hoffmann-La Roche
Hoffmann-La Roche